BeOne Medicines
Luke Stacey has accumulated a diverse and extensive background in the clinical research field, having held various managerial and monitoring roles in different companies such as BeiGene, PSI CRO AG, PPD, and more. With a solid educational foundation in Molecular Biotechnology and Pharmacology from the University of Sydney, Luke has demonstrated a strong ability to oversee the execution of project deliverables, manage clinical resources, track and distribute metric updates, and ensure regulatory compliance in clinical trials. Luke has consistently shown leadership and expertise in handling multiple therapeutic areas and ensuring studies are completed on time and within budget.
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.